Titan Pharmaceuticals (FRA:TN70) Price-to-Operating-Cash-Flow : (As of Jun. 10, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Titan Pharmaceuticals Price-to-Operating-Cash-Flow?

As of today (2024-06-10), Titan Pharmaceuticals's share price is €5.917. Titan Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-7.04. Hence, Titan Pharmaceuticals's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Titan Pharmaceuticals's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, Titan Pharmaceuticals's highest Price-to-Operating-Cash-Flow Ratio was 78.06. The lowest was 8.89. And the median was 14.86.

FRA:TN70's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.02
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Titan Pharmaceuticals's Cash Flow from Operations per share for the three months ended in Mar. 2024 was €-0.66. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-7.04.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 53.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 63.50% per year.

During the past 13 years, Titan Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 74.10% per year. The lowest was -39.00% per year. And the median was 14.00% per year.

Titan Pharmaceuticals Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Titan Pharmaceuticals's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Titan Pharmaceuticals Price-to-Operating-Cash-Flow Chart

Titan Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Titan Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Titan Pharmaceuticals's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Titan Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Titan Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Titan Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Titan Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.

Titan Pharmaceuticals Price-to-Operating-Cash-Flow Calculation

Titan Pharmaceuticals's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	5.917	/	-7.041
	=

Titan Pharmaceuticals's Share Price of today is €5.917.
Titan Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-7.04.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Titan Pharmaceuticals Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Titan Pharmaceuticals's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Titan Pharmaceuticals (FRA:TN70) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Titan Pharmaceuticals Inc (FRA:TN70) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

TTNP:USA

Address

400 Oyster Point Boulevard, Suite 505, South San Francisco, CA, USA, 94080

Website

https://www.titanpharm.com

Titan Pharmaceuticals Inc is a pharmaceutical company developing therapeutics utilizing its proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases for which steady state delivery of a drug provides efficacy and/or safety benefit. ProNeura consists of a small, solid implant made from a mixture of ethylene-vinyl acetate, or EVA, and a drug substance. Its first product based on ProNeura technology was the Probuphine (buprenorphine) implant, which was approved in the United States, Canada and the European Union, for the maintenance treatment of opioid use disorder in clinically stable patients taking 8 mg or less a day of oral buprenorphine.

Titan Pharmaceuticals (FRA:TN70) Headlines

No Headlines